Concordia Healthcare Corp. (NASDAQ:CXRX) dropped -18.31% and closed the trade at $ 5.40. The company recorded a trading capacity of 6.91 million shares above its three months average daily volume of 848.81 thousand shares. During the last trade, shares reached to high price of $5.97 and touched the low price of $4.80. The stock’s 50-day moving average is noted at $11.61 and its 200-day moving average is stands at $22.48.
Additionally, the company has EPS of -13.21. The company has market capitalization of $275.49M.
Currently Concordia Healthcare Corp. (CXRX) captured an average recommendation of “ Hold ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “3″ Analysts”. “1” rated “Sell” for the company. “5” said the company as a “Hold”. Overweight rating was given by “0” and Underweight rating was given by “0”.
Analysts are expecting that the company to achieve $22.45 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $38.83 however minimum price target advised by analysts is $10.10. The Median price target for the stock is measured at $18.12.
Presently, Analysts decided consensus EPS estimate of $1.39 for present quarter and one month ago projected EPS estimate was at $1.38. If we take a look at back 3 month ago, consensus EPS estimate was $2.14.
A current consensus EPS estimate for next quarter is at $1.35 and 3 month ago EPS forecast was $2.28. Have a look at back 1 month ago, consensus EPS forecast was seen at $1.34.
For current fiscal year, most recent EPS estimate is set at $6.53 based on Analyst consensus and three month ago consensus EPS opinions was at $8.22. During period one month ago, consensus EPS forecast was decided at $6.50.
A current consensus EPS projection for next fiscal year is observed at $6.42 and one month ago consensus EPS forecast was at $6.50. Take a look at back three month ago, consensus EPS estimate opinions was decided at $9.99 by analysts.
One Month ago, the stock has gained consensus mean rating of Hold based on the analysis of brokerage analyst firms polled. 3 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0. 5 advised the “Hold” rating about this stock. 1 revealed “Sell” signal and “Underweight” rating was declared by 0.
Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 8 said a “Buy Rating” and 0 announced “Overweight Rating”. 3 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.